Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
Phase of Trial: Phase III
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SAIL
- 10 Jun 2017 Biomarkers information updated
- 20 Jan 2016 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 31 Jul 2014 According to the ClinicalTrials.gov record, planned end date changed to 1 Jun 2015.